Novo Nordisk President & CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.

Angela Stent Talks Ukraine/Russia War
10:13

Stephanie Roth Talks FOMC Minutes, Inflation
09:32

Estonia Prime Minister Kristen Michal Talks Hormuz Security
07:13